Analysis of the effect of halofuginone on bleomycin-induced scleroderma [8]

Rheumatology

Volumn 41, Issue 5, 2002, Pages 594-596

  Yamamoto, T ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; HALOFUGINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; FEMALE; GRAFT VERSUS HOST REACTION; LETTER; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; SKIN FIBROSIS;

ANIMALS; BLEOMYCIN; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; PIPERIDINES; PROTEIN SYNTHESIS INHIBITORS; QUINAZOLINES; QUINAZOLINONES; SCLERODERMA, SYSTEMIC; SPECIFIC PATHOGEN-FREE ORGANISMS; TREATMENT OUTCOME;

EID: 0036263730     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (20)

1. Systemic scleroderma: Clinical and pathophysiological aspects
2. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
3. Animal models of systemic sclerosis
4. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone
5. Halofuginone: An inhibitor of collagen type I synthesis
6. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intima hyperplasia
7. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: Effect of halofuginone
8. Bleomycin-induced synthesis of type I procollagen by human lung and skin fibroblasts in culture
9. Bleomycin treatment of chick fibroblasts causes an increase of polysomal type I procollagen mRNAs
10. A molecular basis for bleomycin induced pulmonary fibrosis
11. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts
12. Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injury
13. Drug-induced pulmonary fibrosis
14. Morphological and biological study of pulmonary changes induced by bleomycin in mice
15. Possible mechanisms of bleomycin-induced fibrosis
16. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma
17. Animal model of sclerotic skin. II: Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/WV mice
18. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains
19. Animal model of sclerotic skin. IV: Induction of dermal sclerosis by bleomycin is T cell independent
20. Reduction in pulmonary fibrosis in vivo by halofuginone